{"name":"Rubius Therapeutics","slug":"rubius-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":96414000,"netIncome":-179666000,"cash":23070000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNcmhxT0xwOEplTmNBSi12Z2pIQ2hBMXpZMzR5MmFjbzIyNUZxN0FaeDRVNXc5ZTZBUkFrOGJqV1d0ZmgxTl80clJ0TVlzODNId3l3V01Qai10aVJjR2FReGpYSHdOX1lEWVZiSHBibGc5MVhKVkhSVlZobE1uWUN1T3dGTFdrWW5BRGtteVRLNGJTZGFxNnNhVkRxRjRSWFI3RmfSAacBQVVfeXFMUGRPZ0JHX25wa2otS0dQRXQwM05hTGUydkhRNlNuRkFYcUhHSUxJTkE2VUpjWEdlNXdCVXRNakVScGxUSWFOQXlZWV8wSDh4Z3hnOHk3ZHNSYXdYR2xJS2NDZVVTMWR4blZjVWhsYkdWZlgxd29BN1EyZjRNdkJGRC0zTzl1azR1N25jbW1hakM5OVhvM0xuZWw3cHpEVnBNbUlwQzVBcEE?oc=5","date":"2024-12-20","type":"pipeline","source":"Pulse 2.0","summary":"Ottimo Pharma: Over $140 Million (Series A) Raised To Advance Bifunctional Medicines - Pulse 2.0","headline":"Ottimo Pharma: Over $140 Million (Series A) Raised To Advance Bifunctional Medicines - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOc0tWcTBjV3FPTW9fNE1rRFhWVzJtcVNydEU3Rm0wVHZvUnNhRUhhQUZCb3VsWjBpY09xc3NFV0hiMUczTUlFelJpdG1JVFJKYzZmX25PeFlZcWRkbmpFSHJJZVdSN1hoSG9EYTAxVldkeUFuSzBybjZzdVdSX0dwYkw2T1huSlU3MllCYnFZalZXQQ?oc=5","date":"2023-05-12","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Incyte plucks ex-Rubius CEO to lead R&D - Fierce Biotech","headline":"Chutes & Ladders—Incyte plucks ex-Rubius CEO to lead R&D","sentiment":"neutral"},{"date":"2023-04-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2023-03-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2023-02-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQU3lLUnZVUnpHRUJkMHhNVGJRMHBYUzV4UmxaaFVzOWNMUlZRSS1wSjI1bmdFOXNra0R5cGotMmNOVnNIb09HXzJkb0Q1N3dYQkdFU2JacnU4LVpaZWlaZFl1SjFIeG90UUxHbGdRLU9tS1psUzFucERDMVhQanNlZ1hwakVLbkRwX1hrRHVQV0ZSd2NiM3VyVUpfenQ3bTJGR0NfOFdTRkhwLWtpUUhZ?oc=5","date":"2023-02-22","type":"pipeline","source":"statnews.com","summary":"Once high-flying Rubius to shut down. Its flameout is a lesson for biotech - statnews.com","headline":"Once high-flying Rubius to shut down. Its flameout is a lesson for biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQdG4xTTZEUmVUc3RvZkI0dHNva0dWLVdaaFdHa3czOWtIQ3c4dkkxeEdYVFk5YmZjM3ItdFN0Ym16RXNmZ0EyMEFMcEFnZXcwZUVxeGJCa3J3OWhadVc3ZG10dUc5MHZkV0lnTFo3SUswWXBYa1N4VDJQQ0gyOF94Mk94TXk?oc=5","date":"2023-02-22","type":"pipeline","source":"BioPharma Dive","summary":"Rubius, after layoffs and executive turnover, sets plan to dissolve - BioPharma Dive","headline":"Rubius, after layoffs and executive turnover, sets plan to dissolve","sentiment":"neutral"},{"date":"2023-02-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA2UnhXVnVvTmpjMGNKSzlXT0s3dTFpaDRkMHRGRmgxTS05ZTBhaGp4RDlad3pQTFRJOHM2QlR3TnVYajVhU0F5a1l4T0h5cFNYVlpnSlBoUlVVb0M3UkNv?oc=5","date":"2023-02-15","type":"pipeline","source":"nature.com","summary":"People - nature.com","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQZ3AycEpVdS1teFlKYzBUZVJRdmtlR0pIbnF3aV9lU0VXN2NJcmNuYjVwbFBXTHVnTEc4bldTblVoOHhSWVV0LUo3ZGtDT3ZId2R4bkhPd3EzQnQxQjA5LUJ0V3RqQW1OYXBpWmVnNGpZVVZEN01JcmZkZzA5Vy11TE56b3l3QW54cDc4cw?oc=5","date":"2022-09-13","type":"pipeline","source":"BioPharma Dive","summary":"Rubius, a once high-flying biotech startup, lays off much of its staff - BioPharma Dive","headline":"Rubius, a once high-flying biotech startup, lays off much of its staff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPUzlCaHFrTzlDYWVqOXptN0FENHBqOTh3MUpyTjlqSDkwU3lWbVhVaUZhTGdHSDFyY2xMQzkweVkwdThiM1FDZTlPNjBoOC1aOHpKa0tRMV9yYTVfeEhmQmxjaUd6cmVIOURWZ0xKb1ZwX3dRSEtjMUV0Sm9UME51MnJCVFhtQW9EcmJvWW5OTnBTM3pCWDJFV25KYTZIazd0RDJPdWliVVI?oc=5","date":"2021-08-30","type":"pipeline","source":"citybiz","summary":"Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer - citybiz","headline":"Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQbk1qbHk3WlNWOEE4OUJUemxHWExMSEtNRjRoc3dRQVdGZ1FxVmZlUWRiSU5rNF8yYU5aVzE4NEoxZVBzVmZrbndFU18tZi1IU09BWXJicmZoUTg2OFNWSUlCS2VLV0NpUnJZQWxIOEVCQi10SGxPTFd1QmtrU0dfRVd0Uk4zdkVhLU5Z?oc=5","date":"2021-03-17","type":"pipeline","source":"pharmaphorum","summary":"Rubius launches $200m IPO to fund red blood cell therapies - pharmaphorum","headline":"Rubius launches $200m IPO to fund red blood cell therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQQk4zbnNnWHhubjNvSGxtbXFZUk4tZ19JR3BhNXJYejUxNjVRVFdhQUxZU29ZelZ5Ni1KRmRLZjUtcF9HNHRxTndMTkduaEJPZFVMWklfMW55MzRMNzN1LWxtYkwyT2lZWjFvMi1mUHk4UV9PWWh2cDVmODRhRVcwbHdQYVJCdFNXWGl3dDh4ZWFhcWozQmt0S2JnanloaVREVlNBSmlmcVY3RkhCVWNmdjhB?oc=5","date":"2020-01-02","type":"pipeline","source":"PMLiVE","summary":"New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals - PMLiVE","headline":"New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQMUdTM29NZ1kwTkN6QTQyNzVUM1dfRGtVR0VBbUxyVEFGeTIxdlpfR21aNmhxREZNMkhmQWdnOURmOHk1V21IcmpsWFhfcnBvZEpYMl93d2dRbWFwdzloUmFPdW9HREFFOVloenBqQlFpak1ISjlZMWt2QUY5aUh3eEtOc0JDNDhuSTBiazZvU0FjRGFHQy0zZHV1cHVNY1ZyU2V6Q2FmQ2twOFhWRVZYUmVxaw?oc=5","date":"2018-09-20","type":"pipeline","source":"Fierce Pharma","summary":"Rubius Therapeutics kicks off $155M renovation of former Alexion plant in Rhode Island - Fierce Pharma","headline":"Rubius Therapeutics kicks off $155M renovation of former Alexion plant in Rhode Island","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPUXFQM3N5dEFXUkt4bHlHUkRwZ3BzMlpFZ2t1am9RZW1PanJEMFVCd2w2eHd1bU8tR2dJSnhPcjVkUXBMZkhUanQxQ0hnQmhOblhPSy1KYjZhdDVaMC10VlBxV1NMY19VY2pjS1lRNjRDS0JHdzc4X2NkdWkyRDdfMXJjeGRwVGNYRGlOSmRDZzJ4RGZtWEJzNm1YUVg0Q3FQN0I3WlNHc0ZZdmZLcmNic3ljeU5OOWtk?oc=5","date":"2018-07-10","type":"pipeline","source":"Fierce Pharma","summary":"Rubius Therapeutics to invest $155M, hire 160 workers for cell therapy plant - Fierce Pharma","headline":"Rubius Therapeutics to invest $155M, hire 160 workers for cell therapy plant","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":0,"period":"2022-12-31"},{"value":0,"period":"2021-12-31"},{"value":0,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":96414000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-179666000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":23070000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}